Literature DB >> 24530887

Oxaliplatin induces hypomyelination and reduced neuregulin 1 expression in the rat sciatic nerve.

Kuniaki Tsutsumi1, Yuji Yamashita2, Soichiro Ushio3, Takehiro Kawashiri4, Takanori Kaname5, Shunsuke Fujita6, Ryozo Oishi7, Nobuaki Egashira8.   

Abstract

Oxaliplatin causes severe peripheral neuropathy. In this study, we examined hypomyelination in the peripheral nerve in oxaliplatin-induced neuropathy rat model. Gene expression of neuregulin 1 (NRG1), a myelination regulatory factor, is reduced in the dorsal root ganglion (DRG) in DNA microarray analysis. Oxaliplatin increased the g-ratio and reduced levels of myelin protein zero in sciatic nerve, suggesting the hypomyelination. Moreover, oxaliplatin reduced NRG1 mRNA levels in the DRG and decreased levels of cleaved NRG1 type III protein in the sciatic nerve. Our results indicate that oxaliplatin induces hypomyelination and reduced NRG1 expression.
Copyright © 2014 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved.

Entities:  

Keywords:  Hypomyelination; Myelin protein zero; Neuregulin; Neuropathy; Oxaliplatin

Mesh:

Substances:

Year:  2014        PMID: 24530887     DOI: 10.1016/j.neures.2014.02.004

Source DB:  PubMed          Journal:  Neurosci Res        ISSN: 0168-0102            Impact factor:   3.304


  9 in total

1.  miR-15b mediates oxaliplatin-induced chronic neuropathic pain through BACE1 down-regulation.

Authors:  Naomi Ito; Atsushi Sakai; Noriko Miyake; Motoyo Maruyama; Hirotoshi Iwasaki; Koichi Miyake; Takashi Okada; Atsuhiro Sakamoto; Hidenori Suzuki
Journal:  Br J Pharmacol       Date:  2017-01-23       Impact factor: 8.739

2.  Oral administration of Cystine and Theanine ameliorates oxaliplatin-induced chronic peripheral neuropathy in rodents.

Authors:  Takehiro Kawashiri; Daisuke Kobayashi; Nobuaki Egashira; Takashi Tsuchiya; Takao Shimazoe
Journal:  Sci Rep       Date:  2020-07-29       Impact factor: 4.379

3.  Neuroprotective effect of alogliptin on oxaliplatin-induced peripheral neuropathy in vivo and in vitro.

Authors:  Nao Shigematsu; Takehiro Kawashiri; Daisuke Kobayashi; Shiori Shimizu; Keisuke Mine; Shiori Hiromoto; Mayako Uchida; Nobuaki Egashira; Takao Shimazoe
Journal:  Sci Rep       Date:  2020-04-21       Impact factor: 4.379

Review 4.  Pathological Mechanisms and Preventive Strategies of Oxaliplatin-Induced Peripheral Neuropathy.

Authors:  Nobuaki Egashira
Journal:  Front Pain Res (Lausanne)       Date:  2021-12-08

5.  Omeprazole Suppresses Oxaliplatin-Induced Peripheral Neuropathy in a Rodent Model and Clinical Database.

Authors:  Keisuke Mine; Takehiro Kawashiri; Mizuki Inoue; Daisuke Kobayashi; Kohei Mori; Shiori Hiromoto; Hibiki Kudamatsu; Mayako Uchida; Nobuaki Egashira; Satoru Koyanagi; Shigehiro Ohdo; Takao Shimazoe
Journal:  Int J Mol Sci       Date:  2022-08-09       Impact factor: 6.208

6.  Pretreatment with Zonisamide Mitigates Oxaliplatin-Induced Toxicity in Rat DRG Neurons and DRG Neuron-Schwann Cell Co-Cultures.

Authors:  Shizuka Takaku; Kazunori Sango
Journal:  Int J Mol Sci       Date:  2022-09-01       Impact factor: 6.208

7.  Muscle Expression of SOD1(G93A) Modulates microRNA and mRNA Transcription Pattern Associated with the Myelination Process in the Spinal Cord of Transgenic Mice.

Authors:  Gabriella Dobrowolny; Camilla Bernardini; Martina Martini; Mirko Baranzini; Marta Barba; Antonio Musarò
Journal:  Front Cell Neurosci       Date:  2015-12-01       Impact factor: 5.505

8.  Exenatide Facilitates Recovery from Oxaliplatin-Induced Peripheral Neuropathy in Rats.

Authors:  Shunsuke Fujita; Soichiro Ushio; Nana Ozawa; Ken Masuguchi; Takehiro Kawashiri; Ryozo Oishi; Nobuaki Egashira
Journal:  PLoS One       Date:  2015-11-04       Impact factor: 3.240

9.  Glial cell line-derived neurotrophic factor (GDNF) attenuates the peripheral neuromuscular dysfunction without inhibiting the activation of spinal microglia/monocyte.

Authors:  Fei Xie; Fan Zhang; Su Min; Jingyuan Chen; Jun Yang; Xin Wang
Journal:  BMC Geriatr       Date:  2018-05-09       Impact factor: 3.921

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.